Article
High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial.
British journal of haematology - 1 Feb 2016
Shiba Norio, Ohki Kentaro, Kobayashi Tohru, Hara Yusuke, Yamato Genki, Tanoshima Reo, Ichikawa Hitoshi, Tomizawa Daisuke, Park Myoung-Ja, Shimada Akira, Sotomatsu Manabu, Arakawa Hirokazu, Horibe Keizo, Adachi Souichi, Taga Takashi, Tawa Akio, Hayashi Yasuhide
Abstract excerpt
Recent reports described the NUP98-NSD1 fusion as an adverse prognostic marker for acute myeloid leukaemia (AML) and PRDM16 (also known as MEL1) as the representative overexpressed gene in patients harbouring NUP98-NSD1 fusion. PRDM16 gene expression levels were measured via real-time polymerase chain reaction in 369 paediatric patients with de novo AML, of whom 84 (23%) exhibited PRDM16 overexpression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
